Machine Learning for Discovery of New ADORA Modulators.
PMID:35814244
Repurposing of FDA-approved drugs as potential inhibitors of the SARS-CoV-2 main protease: Molecular insights into improved therapeutic discovery.
PMID:34986429
Man vs. machine: comparison of pharmacogenetic expert counselling with a clinical medication support system in a study with 200 genotyped patients.
PMID:34958399
Target identification for repurposed drugs active against SARS-CoV-2 via high-throughput inverse docking.
PMID:34825285
DDInter: an online drug-drug interaction database towards improving clinical decision-making and patient safety.
PMID:34634800
A survey on computational methods in discovering protein inhibitors of SARS-CoV-2.
PMID:34623382
virusMED: an atlas of hotspots of viral proteins.
PMID:34614039
Repurposing drug molecule against SARS-Cov-2 (COVID-19) through molecular docking and dynamics: a quick approach to pick FDA-approved drugs.
PMID:34601658
Drug Discovery of Spinal Muscular Atrophy (SMA) from the Computational Perspective: A Comprehensive Review.
PMID:34445667
Individualized Drugs' Selection by Evaluation of Drug Properties, Pharmacogenomics and Clinical Parameters: Performance of a Bioinformatic Tool Compared to a Clinically Established Counselling Process.
PMID:34385834
Computational strategies for the discovery of biological functions of health foods, nutraceuticals and cosmeceuticals: a review.
PMID:34258685
A large-scale computational screen identifies strong potential inhibitors for disrupting SARS-CoV-2 S-protein and human ACE2 interaction.
PMID:33998954
Insilico drug repurposing using FDA approved drugs against Membrane protein of SARS-CoV-2.
PMID:33684397
Supercomputer-Based Ensemble Docking Drug Discovery Pipeline with Application to Covid-19.
PMID:33326239
Bioactivity Comparison across Multiple Machine Learning Algorithms Using over 5000 Datasets for Drug Discovery.
PMID:33325717
Supercomputer-Based Ensemble Docking Drug Discovery Pipeline with Application to Covid-19.
PMID:33200117
PROMISCUOUS 2.0: a resource for drug-repositioning.
PMID:33196798
A review on drug repurposing applicable to COVID-19.
PMID:33147623
Identification of potential Mpro inhibitors for the treatment of COVID-19 by using systematic virtual screening approach.
PMID:32737681
Structure-based drug repositioning over the human TMPRSS2 protease domain: search for chemical probes able to repress SARS-CoV-2 Spike protein cleavages.
PMID:32730844
Advancing computer-aided drug discovery (CADD) by big data and data-driven machine learning modeling.
PMID:32663517
Identification of a druggable binding pocket in the spike protein reveals a key site for existing drugs potentially capable of combating Covid-19 infectivity.
PMID:32611313
Drug repurposing against SARS-CoV-2 using E-pharmacophore based virtual screening, molecular docking and molecular dynamics with main protease as the target.
PMID:32571168
Virtual screening web servers: designing chemical probes and drug candidates in the cyberspace.
PMID:32187356
Machine learning approaches and databases for prediction of drug-target interaction: a survey paper.
PMID:31950972
Evaluating the consistency of large-scale pharmacogenomic studies.
PMID:31846027
A Free Web-Based Protocol to Assist Structure-Based Virtual Screening Experiments.
PMID:31546814
CDEK: Clinical Drug Experience Knowledgebase.
PMID:31411687
Drug repurposing for antimicrobial discovery.
PMID:30833727
Free Accessible Databases as a Source of Information about Food Components and Other Compounds with Anticancer Activity⁻Brief Review.
PMID:30813234
Assessing the public landscape of clinical-stage pharmaceuticals through freely available online databases.
PMID:30690196
Online structure-based screening of purchasable approved drugs and natural compounds: retrospective examples of drug repositioning on cancer targets.
PMID:30190791
Current Strategies and Applications for Precision Drug Design.
PMID:30072901
Caveat Usor: Assessing Differences between Major Chemistry Databases.
PMID:29451740